Company Profile
MM Biolabs is a four year old biotech company involved in both generic and new drug discovery and development. MM Biolabs has two business verticals, products and service including API supply.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Hyaluronic Acid |
Hyaluronic acid;Mucoitin;Luronit;Hyaluronan;Sepracoat;ACP gel;ACP;ACP (polysaccharide);Durolane;Hylartil;Synvisc;Sofast;HA 9;Hylan G-F 20;Genzyme 9983;Hyalofill;Hy 20;Hyaluronsan HA-F;Hyalobarrier gel;Chlamyhyaluronic acid;Q 5AQ;Cystitat;Hyal;Hyruan Plus;Sepragel Sinus;Bio Hyaluro 9;HA-LF;Nutra-HAF;Hyaluronsan HA-LF;Hyaluronsan HA-L 510;Hyaferm;Macronan;FCH-A;Voluma;Biohyalo 12;Juvederm;Juvederm Voluma;Aquify;FCH 120;Hyalo-Oligo;Hyal-Joint;HA-LQ;Xiloial;Amalian I;Amalian II;Amalian III;Amalian Lips;Viscofill Basic;Viscofill Medium;Viscofill Extra;FCH 9;FUH-SU;Hyalorigo;Fluka 53747;PU 98;Mesolis;Emervel;PrimalHyal 300;Juvederm Ultra III;HyStem-C;Ialuset;Excellentha;Elevess;Restylene;Hyalrepair 07M;Hyalrepair 02;Hyacare 50;Hyalofemme;Belotero Balance;Perlane-L;Restylane-L;Hyalobarrier;Termira Auxigel;Oralvisc;Hyaluronsan HA-LF-P;Hilo Komod;Blepharogel;HA 700K1;Modelishape;Eschelissoft;Jolidermis 18;Gel 200;Gel-One;Revie reform;Bellcontour Gvisc;Juvederm Volbella XC;FCH 201P;Gengigel;HAO 1025;Tastex Hyalu 04;9039-38-7;29382-75-0;37243-73-5;165324-65-2;953845-54-0;953845-55-1;953845-56-2;953845-57-3;1257406-45-3;1357910-24-7;1444006-49-8;1623804-64-7;1623804-65-8 |
9004-61-9 | Inquiry | |
RAPAMYCIN |
Rapamycin;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;Antibiotic AY 22989;[3S-[3R*[S*(1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*]]-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-,[3S-[3R*[S*(1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*]]-;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;AY 22989;(-)-Rapamycin;Sirolimus;SIIA 9268A;Rapamune;Rapammune;RPM;NSC 226080;RAPA;Wy 090217;Cypher;Nab rapamycin;Supralimus;14S-Rapamycin;Cypher Bx Velocity;PNP-sirolimus;DE 109;MS-RO01;MS-RO02;MS-RO03;Perceiva;Rapamysin;SVP-R;1179372-35-0;1189166-54-8;1233221-34-5;1353039-01-6 |
53123-88-9 | Inquiry | |
Tacrolimus |
15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-,(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-;15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,[3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-;15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-;(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone;FR 900506;FK 506;Tsukubaenolide;L 679934;Fujimycin;(-)-FK 506;Tacrolimus;Prograf;Protopic;Advagraf;TacroBell;FK506;Prograph;Envarsus XR;Astagraf XL;Hecoria;Tacropic;Protopy;Modigraf;Envarsus |
104987-11-3 | Inquiry | |
Zoledronic Acid |
Phosphonic acid,P,P′-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-;Phosphonic acid,[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-;P,P′-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis[phosphonic acid];(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid;Zoledronic acid;CGP 42446;Zoledronate;Zometa;1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene-1,1-bisphosphonic acid;ZOL 446;2-(Imidazol-1-yl)-1-hydroxy-1,1′-ethylidenediphosphonic acid;BPH 91;Reclast;Orazol;Aclasta;[1-Hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid;(1-Hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic acid |
118072-93-8 | Inquiry |